Prelude Therapeutics Corporate Presentation 2023

Prelude Therapeutics is a clinical-stage biopharmaceutical company developing small molecule precision medicines for cancer treatment. The company's pipeline includes candidates such as PRT1419, PRT2527, PRT3645, PRT3789, and an oral SMARCA2 candidate in various stages of clinical development. With a focus on large commercial opportunities and a well-capitalized R&D engine, Prelude aims to deliver targeted cancer therapies to patients.